A Japanese government panel on Wednesday detailed its plans to strengthen the drug discovery process and deliver the latest medicine to the public, as well as efforts to build a system with a sustainable cycle of investment and innovation.

Japan has a rich history of having discovered various drugs that are used around the world to this day. However, with the recent global transition to biopharmacy and regenerative cell medicine, as well as drug development that utilizes artificial intelligence and pharmacogenomics, the country has been falling behind.

The country has also been facing delays in getting certain new medicines — especially those that deal with rare diseases or are to be administered to children — to patients that need them.